跳至主要内容
临床试验/NCT00319358
NCT00319358已完成3 期

Effect of Antioxidant Supplementation on Pain, Antioxidant Profile and Oxidative Stress in Patients With Chronic Pancreatitis

All India Institute of Medical Sciences, New Delhi2 个研究点 分布在 1 个国家目标入组 127 人开始时间: 2003年10月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
127
试验地点
2
主要终点
Reduction in the number of painful days per month due to chronic pancreatitis

研究概览

简要总结

Chronic pancreatitis is a progressive inflammatory disease of the pancreas that presents with abdominal pain and in late stages may cause diabetes and malnutrition. The pain may be incapacitating and may affect patients physically, mentally and socially. Pain due to chronic pancreatitis is difficult to treat. Oxidative stress and free radical mediated injury has been shown to cause pancreatic inflammation. It has been shown that patients with chronic pancreatitis are deficient in micronutrients and natural antioxidants such as b-carotene, vitamin E and C etc. Studies have suggested that antioxidant supplementation may help to combat pain in these patients. Antioxidant supplementation may decrease the oxidative stress and boost the antioxidant status, thereby resulting in pain relief. The investigators have planned to perform a trial to study the effect of antioxidant supplementation on pain relief in patients with chronic pancreatitis.

详细描述

INTRODUCTION Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas accompanied by abdominal pain and in late stages, by exocrine and endocrine insufficiency. The etiology of CP include alcohol abuse, hereditary, ductal obstruction, tropical pancreatitis, systemic diseases (systemic lupus erythematosus and cystic fibrosis etc.), and idiopathic. Alcohol abuse accounts for 70-80% of cases of chronic pancreatitis in the West and about 40% in India. The intensity of injury depends on the duration and amount of alcohol consumed. Hereditary pancreatitis transmitted as an autosomal dominant trait accounts for a small subset of all cases of CP, and occurs due to mutation in cationic trypsinogen gene. Pancreatic duct obstruction may be secondary to trauma, pseudocysts, calcific stones or tumors and leads to obstructive CP (1). Tropical pancreatitis is a condition of unknown etiology that is seen predominantly in south India and other tropical areas of the World. Young patients are commonly affected with this disease. Cassava consumption had been proposed as an etiological factor due to its cyanogenic glycoside content however no epidemiological study has proved this hypothesis (2). Malnutrition has been suggested as an etiological factor in tropical pancreatitis. Idiopathic pancreatitis accounts for a substantial number of cases.

Many recent studies have emphasized a role for Reactive Oxygen Radicals (ROR) in the development of oxidative stress and hence inflammation in the pathogenesis of chronic pancreatitis. Increased oxidative stress probably results from increased exposure to xenobiotics. Xenobiotics are chemical substances present in the environment to which human beings are constantly exposed. It is conceivable that many of these xenobiotics are metabolized in pancreas that contains cytochrome P450 (CYP450) enzymatic system. The metabolism of xenobiotics occurs through two phases, Phase I and Phase II. Phase I metabolism may result in 'bioactivation' of the xenobiotics, in turn activating CYP system. Phase II involves attachment of biotransformed compound to a biological molecule that makes it more polar and thus easier to excrete. The metabolism of xenobiotics places an oxidative stress and can overwhelm the natural antioxidant defense of the body. The resultant production of the free radicals may play an important role in the pathogenesis of CP (2). Over induction of this enzyme can cause increased utilization of glutathione (GSH), which causes irreversible loss of glutathione. Moreover glutathione serves as a reservoir for cysteine/cystine required for disulphide synthesis for pancreatic digestive proteins. This further aggravates the situation. Three types of cytochrome enzymes are induced through xenobiotics. CYP2E1 has been specifically examined in the context of liver injury. CYP1A metabolizes smoke constituents and potent carcinogens such as benzo(a)pyrene. Cytochrome 3A is inducible by reactive oxygen species generated from aflatoxin B1. Alcohol, nicotine from cigarette smoke and other forms of tobacco consumption and industrial pollutants all are considered as xenobiotics and overwhelm the detoxification capacity of cytochrome CYP450 system (3). The CYP induction increases heme and heme-oxygenase thus buttressing the antioxidant defenses. The free radical peroxidation products may act as second messengers and block exocytosis leading to increased autophagy and crinophagy thus diverting the pancreatic enzymes into interstitium. This leads to degranulation of mast cells inducing inflammation mediated by chemotaxis. The synthesis of enzyme proteins in pancreas also produces H2O2, which also induces free radical production. Furthermore the depressed methionine trans-sulphuration pathway induces CYP as well. The free radicals generated from all these processes induce oxidative stress, which is implicated in damage to cell membranes due to lipid peroxidation. Above all, if the antioxidant levels of an individual are may be low due to either low intake or depletion during oxidative stress. Some studies also indicate that free radicals cause disintegration of antioxidative enzymes if over exposed to them.

However, the role of oxidative stress still not fully explained in that whether the oxidative stress is the cause of chronic pancreatitis or a consequence of it. This can be established by two observations: 1) If the oxidative stress is noted before the onset of disease and 2) If the disease symptoms are relieved by supplementation with antioxidants. Patients with alcoholic pancreatitis have been shown to have an increased oxidative stress. Supplementation with antioxidants hence decreases the production of such free radicals and may be beneficial to patients with CP (4).

A study by Braganza et al has shown that CP involves oxidative stress in-patients with CP (5). This was the first study to indicate the role of free radicals in the pathogenesis of chronic pancreatitis. However, the mechanism by which it occurs is still unclear. The preliminary studies show that malondialdehyde (MDA); a marker of peroxidation secondary to oxidative stress increases during CP.

In the present proposed study, the aim is to find out if there is increased oxidative stress in patients with CP and if supplementation with antioxidants relieves pain in them in order to establish a relationship between oxidant stress and pathophysiology of chronic pancreatitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CP with significant pain i.e., at least one episode of pain in a month requiring oral analgesic or one episode of severe pain in last three months requiring hospitalization

排除标准

  • Painless disease
  • Current pain more likely due to non-pancreatic origin
  • If the patient already has an intervention in the form decompressive therapy i.e., surgery or endoscopic sphincterotomy/ stenting or ESWL
  • Systemic conditions like CRF, malignancy, hypertension, and pregnancy
  • Complications like pseudocyst, pancreatic abscess
  • Patients who would have received antioxidants in the preceding 4 weeks
  • Narcotic addicts
  • Uncontrolled diabetes
  • Comorbid conditions like liver diseases

结局指标

主要结局

Reduction in the number of painful days per month due to chronic pancreatitis

时间窗: 6 months

次要结局

  • Decrease in no. of severe attacks requiring hospitalization(6 months)
  • Percentage of patients who are pain-free(6 months)
  • Increase in markers of antioxidant defense in the intervention group compared to placebo group and decrease in oxidative stress parameters in patients after intervention compared to placebo(6 months)

研究者

发起方
All India Institute of Medical Sciences, New Delhi
申办方类型
Other

研究点 (2)

Loading locations...

相似试验